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MEDICAL BOARD OF CALIFORNIA 
Executive Director, Kimberly Kirchmeyer: (916) 263-2389 ♦ License Verification, 
General Licensing, Application and Complaint Information (Toll-Free): 1-800-633-2322 
♦ Office of Public Affairs: (916) 262-2394 ♦ Website: www.mbc.ca.gov  
Protection of the public shall be the highest priority for the Medical Board 
of California in exercising its licensing, regulatory, and disciplinary 
functions. Whenever the protection of the public is inconsistent with other 
interests sought to be promoted, the protection of the public shall be 
paramount.  




he Medical Board of California (MBC) is a consumer protection 
agency within the state Department of Consumer Affairs (DCA). The 
15-member Board consists of eight physicians and seven public 
s. MBC members are appointed by the Governor (who appoints all eight physicians 
and five public members), the Speaker of the Assembly (one public member), and the 
Senate Rules Committee (one public member). Members serve a four-year term and may 
be reappointed to a second term. The Board is assisted by several standing committees and 
ad hoc task forces.  
The purposes of MBC are to protect consumers from incompetent, grossly 
negligent, unlicensed, impaired, or unethical practitioners; enforce the provisions of the 
Medical Practice Act, Business and Professions Code section 2000 et seq.; provide public-
record information about physicians to the public via its website and individual requests; 
and educate healing arts licensees and the public on health quality issues. The Board’s 
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MBC is responsible for ensuring that all physicians licensed in California have 
adequate medical education and training. In this regard, the Board issues regular and 
probationary licenses and certificates under its jurisdiction, administers a continuing 
medical education program, and administers physician and surgeon examinations to some 
license applicants. MBC also oversees the regulation of licensed midwives; 
polysomnographic technologists, technicians, and trainees; research psychoanalysts; and 
medical assistants.  
In response to complaints from the public and reports from health care facilities and 
other mandated reporters, MBC reviews the quality of medical practice carried out by 
physicians and surgeons. In this regard, MBC’s responsibilities include enforcement of the 
disciplinary, administrative, criminal, and civil provisions of the Medical Practice Act. 
MBC’s enforcement staff receives and evaluates complaints and reports of misconduct and 
negligence against physicians. If there is reason to suspect a violation of the Medical 
Practice Act, an investigator from DCA’s Health Quality Investigation Unit (HQIU), 
together with a deputy attorney general (DAG) from the Health Quality Enforcement 
Section (HQE) in the Attorney General’s Office, will investigate the allegations and may 
file charges against alleged violators. Barring a stipulated settlement, the HQE DAG will 
prosecute the charges at an evidentiary hearing before an administrative law judge (ALJ) 
from the special Medical Quality Hearing Panel within the Office of Administrative 
Hearings (OAH). Following the hearing, a seven-member panel of MBC reviews the ALJ’s 
proposed decision and takes final disciplinary action to revoke, suspend, or restrict the 
license, or impose other appropriate administrative action.  
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MBC meets approximately four times per year; its committees and task forces hold 
additional separate meetings as the need arises.  
At this writing, the Board has three vacancies—one physician member and two 
public members—all of which must be filled by Governor-elect Gavin Newsom.  
MAJOR PROJECTS 
Legislative Oversight Hearing Regarding Patient 
Protection  
On June 18, 2018, the Senate Committee on Business, Professions and Economic 
Development Committee convened an oversight hearing, entitled “Sexual Misconduct 
Reporting in the Medical Profession: Missed Opportunities to Protect Patients,” to examine 
health practitioner discipline, and to provide Committee members information about 
current reporting requirements and potential loopholes in the law. The hearing was a 
response to the public outcry after news reports that hundreds of women had complained 
to the University of Southern California (USC) about its student health center’s 
gynecologist, George Tyndall, and his pattern of sexual misconduct for decades. New 
reports revealed that university officials did not report Dr. Tyndall to law enforcement or 
to MBC at the time they became aware of the misconduct. This scandal, combined with 
2016 revelations of similar issues occurring at Michigan State University and USA 
Gymnastics with respect to sports physician, Larry Nassar, gave rise to the hearing. 
Attorney Lowell Brown of Arent Fox LLP (MBC expert), MBC Executive Director 
Kirchmeyer, MBC Staff Counsel Kerrie Webb, Supervising Deputy Attorney General Jane 
Zack Simon, and T. Scott Vivona from the California Department of Public Health all 
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testified before the oversight hearing, discussing the statutory reporting requirements and 
common issues or loopholes they have come across in their work.  
This hearing likely prompted the legislature to pass SB 1448 (Hill) (Chapter 570, 
Statutes of 2018), which requires doctors on probation for specified offenses, including 
sexual misconduct, to affirmatively disclose their probationary status to their patients. [See 
LEGISLATION] 
Cannabis for Medical Purposes 
At its April 2018 meeting, MBC discussed proposed revisions to its Guidelines for 
Recommending Cannabis for Medical Purposes (“Guidelines”). The Guidelines were 
developed, following California’s legalization of cannabis as a permissible treatment 
modality, to assure physicians who choose to recommend cannabis for medical purposes 
to their patients that they will not be subject to investigation or discipline provided they are 
recommending in accordance with accepted standards of medical responsibility. The 
revised Guidelines cover a myriad of medical cannabis-related issues, including the 
physician-patient relationship (as discussed in Business and Professions Code section 
2525.2 and Health and Safety Code section 11362.7(a)); patient evaluation (as discussed 
in Business and Professions Code section 2525.3); informed and shared decision making; 
treatment agreements (or “treatment plans”); qualifying conditions; ongoing monitoring 
and adapting of the treatment plan; consultation and referral; and medical record 
maintenance (pursuant to Business and Professions Code section 2266); and physician 
conflicts of interest (as discussed in Business and Professions Code sections 2525, 650.01, 
and 2525.4).  
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MBC originally adopted the Guidelines at MBC’s October 2017 meeting [23:2 
CRLR 58]. Additionally, at its April 2018 meeting, MBC member Kristina Lawson gave 
an overview of the proposed revisions, mostly minor and technical in nature, to the 
Guidelines. The Board voted to approve the revised Guidelines, and directed staff to post 
them on the Board’s website and notify physicians about the revised Guidelines.  
After the vote, Board President, Dr. GnanaDev announced that MBC’s Marijuana 
Task Force would disband because MBC approved the revised Guidelines, so no further 
action was needed. 
Detection of Overprescribing Physicians:  
CURES 2.0 
On October 2, 2018, the statutory mandate became effective, requiring prescribers 
to consult the Controlled Substance Utilized Review and Evaluation System (CURES 2.0) 
before issuing a prescription for Schedule II, III, or IV controlled substances to a patient 
for the first time (and at least once every four months thereafter if the substance remains 
part of the patient’s treatment plan). The Department of Justice (DOJ) certified CURES 
ready to use on a statewide basis in April of 2018, triggering the six month window before 
mandatory compliance pursuant to SB 482 (Lara) (Chapter 708, Statutes of 2016).  
Pursuant to section 11165.4(d) of the Health and Safety code, MBC is authorized 
to impose administrative sanctions on physicians who fail to consult CURES. [23:2 
CRLR 53]  
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MBC Releases App to Track Physician Discipline 
At the Board’s July 2018 meeting, Executive Director Kirchmeyer gave a brief 
overview of MBC’s newly developed, self-titled iOS application, which the Board released 
in the summer of 2018. The application, which is free, allows users to “follow” up to 
sixteen physician licenses, and receive automated license alert notifications if the physician 
has his or her license suspended, revoked, or placed on probation, or is subject to 
administrative actions. App users will also be notified when one of their selected 
physician’s name, address, practice statute, license expiration or survey data change. The 
application is available to use 24/7, and MBC released a flyer introducing the application 
when it was released. Ms. Kirchmeyer reported that once the iOS version of the application 
is working well, the Board will redevelop the application to also work on Android devices.  
At the meeting, several consumer advocate provided public comment noting that 
while the application improves consumer protection it should not be a replacement for 
affirmative physician disclosure of probationary status to patients. [See LEGISLATION]  
Proposed Changes to Regulations Regarding 
Notice to Patients and Clients 
At its July meeting, MBC staff counsel presented proposed amendments and 
additions to the Board’s regulations pertaining to patient notification about the Board for 
the Board’s discussion and approval. SB 798 (Hill) (Chapter 775, Statutes of 2017) added 
section 2026 to the Business and Professions Code, which requires the Board to  
initiate the process of adopting regulations on or before January 1, 2019, to 
require its licentiates and registrants to provide notice to their clients or 
patients that the practitioner is licensed or registered in this state by the 
board, that the practitioner’s license can be checked, and that complaints 
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against the practitioner can be made through the board’s Internet Web site 
or by contacting the board. 
Specifically, staff proposed amending sections 1355.4 and 1379.58, Title 16 of the 
CCR to conform to the statutory language, including that the notification be made in the 
patient’s primary language, and adding sections 1378.5 and 1379.4 to impose similar notice 
requirements on research psychoanalysts and licensed midwives, respectively.  
Multiple MBC members and a representative from the California Medical 
Association voiced concerns regarding the language accessibility of the Board’s materials 
under the proposed requirements. Ms. Webb then explained that various proposals and 
suggestions to make the Board’s notice materials downloadable in multiple languages is 
within the Board’s authority. After discussion, the Board unanimously voted to approve 
and submit the proposed regulations to DCA for review. 
Mexico Pilot Program Orientation Program 
At its July 2018 meeting, April Alameda, Chief of Licensing for MBC, discussed 
the “Mexico Pilot Program” in length. Ms. Alameda explained that the program, first 
approved by legislation in 2003, was intended to allow up to 30 Mexico-licensed 
physicians specializing in a variety of practice areas to practice in medically underserved 
parts of California for a period of three years. Each physician selected under the program 
is required to complete an MBC-approved, six-month orientation program on the 
California health care delivery system before coming to California. However, the Board 
never received proper funding to support and implement the program.  
The Board is required to approve of the pilot program’s orientation program before 
selected individuals take the course. Board staff conducted an initial review of the course 
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curriculum before turning it over to a Board Licensing Medical Consultant, Dr. Mark 
Servis. Dr. Servis conducted a thorough review of the orientation program and its 
curriculum and had several critiques of the program which he sent back to the pilot 
program. The pilot program incorporated the necessary changes and Dr. Servis received 
back a “comprehensively modified curriculum with significant modifications.”  
Dr. Maximiliano Cuevas, Chief Executive Officer of the Clinica de Salud in 
Salinas, discussed his support of the pilot program, its intended goals, and the potential 
benefits it may produce. Arnoldo Torres, a private policy consultant and author of the 
above-referenced legislation that greenlit the pilot program, noted the difficulties in getting 
the program implemented and clarified the eligibility requirements for the program. 
Finally, Dr. Hannah Rhee voiced her support for including diversity and language training 
as part of the orientation program and training process. The Board voted to approve the 
Mexico Pilot Program. 
LEGISLATION 
SB 1448 (Hill), as amended August 23, 2018, adds sections 2228.1 and 2228.5 to 
the Business and Professions Code. Section 2228.1 requires certain MBC licensees to 
affirmatively disclose their (1) probation status, (2) the length of the probationary period, 
(3) the end date of the probationary period, (4) any and all practice restrictions placed on 
the licensee by MBC, (5) MBC’s telephone number, and (6) an explanation of how the 
patient can access the licensee’s profile page on MBC’s website to get further information 
about the licensee’s probation. MBC licensees on probation will have to affirmatively 
disclose the above information to a patient (or to the patient’s guardian or health care 
surrogate) before the patient’s first appointment following the probationary order. The 
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bill’s affirmative disclosure provisions are triggered when—as established by an MBC 
administrative hearing, admission by licensee, or prima facie showing in a settlement 
agreement—a licensee has: (1) committed sexual abuse or misconduct with a patient; (2) 
abused drugs or alcohol resulting in patient harm or impairment of the licensee’s ability to 
safely practice medicine; (3) been criminally convicted for a crime which directly involved 
harm to a patient; or (4) abused medication prescribing privileges resulting in patient harm 
and a probationary period of at least five years. Section 2228.5 further provides that 
patients must sign a copy of the disclosure notice required by the section and that the 
patient-signed disclosure notice is inapplicable if (1) the patient (or the patient’s guardian 
or health care surrogate) was unable to understand the disclosure notice, (2) the patient’s 
visit is due to a time-sensitive medical emergency, (3) the licensee serving as the treating 
physician is not known to the patient prior to the patient’s visit, or (4) the licensee is not 
directly treating the patient. Finally, the section requires MBC to post information related 
to licensee probation in plain sight on the licensee’s profile page on the MBC website. 
[23:2 CRLR 54]  
Sections 2228.1 and 2228.5 become effective on July 1, 2019. Governor Jerry 
Brown signed SB 1448 on September 19, 2018 (Chapter 570, Statutes of 2018).  
AB 2487 (McCarty), as amended August 8, 2018, adds section 2190.6 to the 
Business and Professions Code. Existing section 2190.5 requires physicians and surgeons 
to complete twelve credit hours of continuing medical education (CME) in the subjects of 
pain management and the treatment of terminally ill and dying patients. New section 
2190.6 provides that as an alternative to the CME requirement in 2190.5, licensed 
physicians and surgeons may complete a one-time CME course of twelve credit hours in 
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the subjects of treatment and management of opiate-dependent patients, including eight 
hours of buprenorphine (or related) treatment for opioid-dependent patients. If a licensed 
physician or surgeon meets the requirements of a “qualifying physician” as defined by the 
Comprehensive Addiction Recovery Act of 2016 (CARA), the licensee is exempt from the 
above provision in section 2190.6. Licensed physicians and surgeons who choose to 
comply with section 2190.6 as an alternative to complying with section 2190.5 (as allowed 
by this section) are required to satisfy the provisions of the section 2910.6 by his or her 
next upcoming license renewal date. Finally, section 2910.6 stipulates that MBC shall 
determine whether a licensed physician or surgeon has met the section’s requirements.  
Governor Jerry Brown signed AB 2487 on September 7, 2018 (Chapter 301, 
Statutes of 2018).  
SB 1109 (Bates), as amended August 24, 2018, amends sections 2190.5, 2191, and 
2196.2 of the Business and Professions Code to adjust existing mandatory CME course 
content, on pain management and treating terminally ill patients, for physician and 
surgeons licensed on or after January 1, 2019, to include materials covering the risks 
associated with the use of Schedule II drugs. Amended section 2191 specifically directs 
MBC to give “highest priority” to developing a CME course on pain management and the 
risk of addiction associated with the use of Schedule II drugs. Finally, amended section 
2196.2 requires MBC to develop and distribute educational and informational materials 
regarding pain management techniques and the risk of addiction associated with the use of 
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Governor Jerry Brown signed SB 1109 on September 22, 2018 (Chapter 693, 
Statutes of 2018).  
AB 2760 (Wood), as amended August 15, 2018, adds Article 10.7 (commencing 
with section 740) to the Business and Professions Code to require prescribers to offer 
prescriptions for naloxone hydrochloride or another federally-approved drug approved for 
the partial or complete reversal of opioid depression (a life-threatening slowing of the 
central nervous and respiratory systems that occurs after an opioid overdose) to a patient 
when certain specified conditions are present. Article 10.7 also requires prescribers to 
provide educational and informational materials for their patients on overdose prevention 
and the use of naloxone hydrochloride or other similarly-purposed and federally-approved 
drugs.  
Governor Jerry Brown signed AB 2760 on September 10, 2018 (Chapter 324, 
Statutes of 2018).  
AB 2783 (O’Donnell), as amended August 22, 2018, amends sections 11055 and 
11056 of the Health and Safety Code to reclassify certain specified hydrocodone 
combination products as Schedule II controlled substances. Re-classifying specified 
hydrocodone combination products as Schedule II controlled substances imposes more 
stringent requirements on the prescribing of hydrocodone combination products, including 
a limitation on refills.  
Governor Jerry Brown signed AB 2783 on September 20, 2018 (Chapter 589, 
Statutes of 2018).  
AB 1751 (Low), as amended August 24, 2018, amends section 11165 of the Health 
and Safety Code to authorize the California Department of Justice (DOJ) to share 
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prescription records directly with the state’s drug monitoring programs (PDMP), the 
Controlled Substance Utilization Review and Evaluation System (CURES), and databases 
across state lines without having to go through a data share hub provided California patient 
privacy and data security regulations and standards are met and observed. Section 11164 
also requires the DOJ to, no later than July 1, 2020, adopt regulations related to accessing 
and using the information stored in CURES. MBC previously voted unanimously to 
support AB 1751 [23:2 CRLR 57] and did so again at its July 2018 meeting on the condition 
that the bill is amended to remove the ability of health plans and insurers to access CURES.  
Governor Jerry Brown signed AB 1751 on September 18, 2018 (Chapter 478, 
Statutes of 2018).  
AB 1753 (Low), as amended August 24, 2018, amends sections 11161.5, 11162.1, 
and 11165 of the Health and Safety Code to allow the DOJ to, by January 1, 2020, limit or 
reduce the number of approved security printers for controlled substance prescription pads 
to three. [23:2 CRLR 58] Additionally, the amended sections require controlled substance 
prescription forms to have individualized, unique serial numbers and require each printer 
to submit certain information to the DOJ for each dispensed prescription form. The 
purported purpose of requiring each prescription pad to be serialized and linked to CURES 
is to help law enforcement better identify the circulation of fake prescriptions written using 
lost or stolen prescription pads. [23:2 CRLR 58] Dispensing pharmacies, clinics, and other 
dispensers are also required to include each prescription form’s serial number in applicable 
reports submitted to the DOJ.  
Governor Jerry Brown signed AB 1753 on September 18, 2018 (Chapter 479, 
Statutes of 2018).  
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AB 2086 (Gallagher), as amended August 14, 2018, adds section 11165.6 to the 
Health and Safety Code to allow prescribers to access CURES for a list of patients for 
whom that prescriber is listed as a prescriber in CURES.  
Governor Jerry Brown signed AB 2086 on September 6, 2018 (Chapter 274, 
Statutes of 2018).  
AB 1996 (Lackey), as amended August 14, 2018, would have amended Business 
and Professions Code section 2525.1 to require MBC to consult with the California 
Cannabis Research Program regarding the development and adoption of medical guidelines 
for the appropriate administration and use of medicinal cannabis. AB 1996 passed floor 
votes in both the Assembly and the Senate but was vetoed by Governor Jerry Brown on 
September 20, 2018. In his veto message, Governor Brown stated that  
I am returning Assembly Bill 1996 without my signature.  
This bill renames the California Marijuana Research Program as the 
California Cannabis Research Program and expands the areas of research 
that can be undertaken. The bill also prohibits the money appropriated to 
the Cannabis Research Program from the Cannabis Tax Fund to pay for the 
provisions of this bill.  
This bill contains provisions that directly conflict with the Control, 
Regulate, and Tax Adult Use of Marijuana Act, which the voters approved 
in November 2016. For this reason, I cannot support this measure. 
 
AB 710 (Wood), as amended April 2, 2018, adds section 26002 to the Business and 
Professions Code and section 11150.2 to the Health and Safety Code to allow a physician, 
pharmacist, or other authorized healing arts licensee acting within their scope of practice 
to prescribe, furnish, or dispense cannabidiol (CBD) if cannabidiol is excluded from 
Schedule I classification under the federal Controlled Substances Act and placed on a 
schedule other than Schedule I or if the United States Food and Drug Administration 
approves a cannabidiol product. [23:2 CRLR 59]  
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AB 710 was an urgency statute, and as such took effect as soon as the governor 
signed it. Governor Jerry Brown signed AB 710 on July 9, 2018 (Chapter 62, Statutes of 
2018).  
AB 1791 (Waldron), as amended April 2, 2018, adds section 2191.4 to the 
Business and Professions Code to require MBC to consider including a continuing 
education course integrating HIV/AIDS pre-exposure prophylaxis (PrEP) and post-
exposure prophylaxis (PEP) medication maintenance and counseling in primary care 
settings. MBC had previously been directed by its staff to take a neutral position on AB 
1791; historically, MBC has opposed bills requiring physicians to take certain CME 
courses. [23:2 CRLR 60]  
Governor Jerry Brown signed AB 1791 on July 18, 2018 (Chapter 122, Statutes of 
2018).  
AB 2311 (Arambula), as introduced February 13, 2018, amends section 2066.5 of 
the Business and Professions Code to permanently authorize a clinical instruction program 
for some certain international medical graduates (IMGs) at the University of California at 
Los Angeles’ David Geffen School of Medicine as part of the School of Medicine’s 
existing pre-residency training program. Each participating IMG must graduate from an 
MBC-recognized medical school at the time of their selection for the program. AB 2311 
also eliminates a sunset provision in the Business and Professions Code that would have 
ended the program on January 1, 2019. As such, the operation of the provisions in section 
2066.5 is set to continue indefinitely.  
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AB 505 (Caballero), as amended June 28, 2018, amends section 2334 of the 
Business and Professions Code to authorize an administrative law judge to extend the time 
period for the exchange of information regarding the use of expert testimony in matters 
brought by MBC, upon a motion based on a showing of good cause, for a period not to 
exceed 100 calendar days.  
Governor Jerry Brown signed AB 505 on September 18, 2018 (Chapter 469, 
Statutes of 2018).  
AB 2461 (Flora), as amended May 25, 2018, amends section 11105.2 of the Penal 
Code to require the DOJ to provide notice and updates to MBC regarding arrests or 
dispositions involving a licensee. The amended section also requires DOJ provide notice 
to the State Department of Social Services and to the Osteopathic Medical Board.  
Governor Jerry Brown signed AB 2461 on September 7, 2018 (Chapter 300, 
Statutes of 2018).  
AB 2789 (Wood), as amended August 14, 2018, adds section 688 to the Business 
and Professions Code to require health care practitioners authorized to prescribe to have 
the capability to transmit electronic data transmission prescriptions. Section 688 requires 
pharmacies to have capability to receive data transmission prescriptions. Under section 
688, beginning January 1, 2022, health care practitioners, currently authorized to prescribe 
using oral, written, or electronic transmission, are required to prescribe exclusively using 
electronic data transmission prescriptions unless: 1) the prescription is for a Class II 
controlled substance; 2) electronic data transmission is not available due to a temporary 
technological or electrical failure; 3) the prescriber is issuing a prescription which will be 
filled by a pharmacy located outside California; or 4) the prescription is issued in a hospital 
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emergency department and one or more of the following conditions are present: (a) patient 
lives outside of California, (b) patient lives outside the geographic area of the treating 
hospital, (c) patient is homeless or indigent and does not have a preferred pharmacy, or (d) 
prescription is issued at a time when the patient’s regular or preferred pharmacy is likely 
to be closed.  
A pharmacy must immediately notify the prescriber if an electronic data 
transmission prescription is not appropriately received or transfer or forward the 
prescription to another pharmacy at the request of the patient. Health care practitioners, 
pharmacists, or pharmacies that provide health care services to certain individuals under 
the jurisdiction of the California Department of Corrections and Rehabilitation are exempt 
from the above provisions of section 688. MBC had mixed reactions to AB 2789, with 
some members arguing that mandating electronic prescriptions will help eliminate 
prescription fraud while other members were concerned with physician access to 
appropriate technology. [23:2 CRLR 64]  
Governor Jerry Brown signed AB 2789 on September 17, 2018 (Chapter 438, 
Statutes of 2018).  
AB 2968 (Levine), as amended August 14, 2018, amends sections 337 and 728 of 
the Business and Professions Code to transfer the responsibility to prepare, develop, and 
disseminate an informational brochure for victims of psychotherapist-client sexual contact 
and their advocates to MBC and other related regulatory boards from DCA which is 
currently responsible for developing the brochure in conjunction with the office of 
Criminal Justice Planning and the office of the Attorney General. The brochure must be 
provided to each individual contacting said boards regarding psychotherapist-sexual 
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contact and behavior. AB 2986 also revises some of the brochure’s content by expanding 
the list of mental health practitioners included in the “psychotherapist” definition, and 
requires the brochure be made available on the website of MBC and the website of the 
other regulatory boards covered by the bill. [23:2 CRLR 64-65]  
Governor Jerry Brown signed AB 2968 on September 26, 2018 (Chapter 778, 
Statutes of 2018).  
SB 1163 (Galgiani), as amended August 24, 2018, amends section 27521 of the 
Government Code to require postmortem examinations and autopsies performed on 
unidentified human remains to be completed by a board-certified forensic pathologist, 
rather than a coroner. Section 27521 also requires agencies tasked with exhumations to 
consult with a board-certified forensic pathologist when performing exhumations.  
Governor Jerry Brown signed SB 1163 on September 29, 2018 (Chapter 936, 
Statutes of 2018).  
SB 1495 (Committee on Health), as amended June 14, 2018, makes 
noncontroversial changes to numerous sections of the Business and Professions Code, the 
Health and Safety Code, and the Welfare and Institutions Code. Importantly, SB 1495 
clarifies language in SB 512 (Hernandez) (Chapter 428, Statutes of 2017) related to patient 
notification requirements during the course of non-FDA approved stem cell therapy. [23:2 
CRLR 66-67] The bill specifies that stem cell therapies meeting the criteria of sections 
1271.10 and 1271.15, Title 21 of the Code of Federal Regulations (i.e., FDA-regulated 
stem cell therapies that do not require FDA premarket review or clearance or stem cell 
therapies that qualify for an exception) do not fall under the purview of the bill’s notice 
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requirements. [23:2 CRLR 66-67] SB 1495 also adds section 1751.5 to the Health and 
Safety Code to prescribe the procedures for hospice licensure.  
Governor Jerry Brown signed SB 1495 on September 14, 2018 (Chapter 424, 
Statutes of 2018).  
AB 2138 (Chiu and Low), as amended August 24, 2018, amends sections 7.5, 480, 
481, 482, 488, 493 and 11345.2 and adds section 480.2 to the Business and Professions 
Code. AB 2138 limits the circumstances under which state regulatory boards under the 
DCA may deny professional licensure to individuals who have previously been convicted 
of certain specified crimes in the 7 years preceding the date of application and requires 
DCA boards to develop criteria for determining whether a crime is directly and adversely 
related to the qualifications, functions, or duties of the business or profession a board 
regulates; develop procedures when requesting or taking disciplinary action based on an 
applicant’s criminal history; and requires boards to annually report specified de-identified 
information relating to Board action pertaining to applicants with criminal convictions, 
including the number of licensees who were affected, whether they provided evidence of 
rehabilitation or mitigation; whether they appealed; the final disposition; and the 
voluntarily provided information on the race or gender of any applicant. [23:2 CRLR 67]  
AB 2138’s provisions become operative on July 1, 2020. Governor Jerry Brown 
signed AB 2138 on September 30, 2018 (Chapter 995, Statutes of 2018).  
AB 2193 (Maienschein), as amended August 17, 2018, adds section 1367.625 and 
Article 6 (commencing with section 123640) to the Health and Safety Code and adds 
section 10123.867 to the Insurance Code to require, by July 1, 2019, licensed health care 
practitioners who provide prenatal or postpartum care for mothers to offer screens for 
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maternal mental health conditions. Health care service plans and health insurers must 
develop maternal mental health programs consistent with sound and accepted clinical 
principles and processes by July 1, 2019. Neither section 1367.625 nor section 10123.867 
apply to certain specialized health insurers.  
Governor Jerry Brown signed AB 2193 on September 26, 2018 (Chapter 755, 
Statutes of 2018).  
AB 1790 (Salas and Fong), as amended August 23, 2018, adds Part 7.7 
(commencing with section 122475) to and repeals section 122477 from the Health and 
Safety Code. AB 1790 establishes the Valley Fever Education, Early Diagnosis, and 
Treatment Act to require the California Department of Public Health to conduct a valley 
fever awareness campaign to communicate the dangers of valley fever to local health 
jurisdictions, providers, and the public. AB 1790 also allows the Department of Public 
Health to award grants or enter into contracts to perform activities related to the awareness 
campaign. AB 1790 contains a sunset provision that makes the above provisions 
inoperative on January 1, 2021.  
Governor Jerry Brown signed AB 1790 on September 11, 2018 (Chapter 338, 
Statutes of 2018).  
AB 1659 (Low), as amended January 3, 2018, amends sections 701, 702, and 703 
of the Business and Professions Code to prohibit holders of inactive licenses from 
representing that they have active licenses. Section 703 also authorizes MBC and other 
applicable DCA boards to charge lower inactive license renewal fees.  
Governor Jerry Brown signed AB 1659 on September 5, 2018 (Chapter 249, 
Statutes of 2018).  
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SB 1480 (Hill), as amended August 24, 2018, amends over a dozen sections, and 
adds numerous sections to the Business and Professions Code; and amends numerous 
sections of the Health and Safety Code. SB 1480 requires all DCA boards to meet at least 
two times a year and requires the Director of DCA to amend existing complaint 
prioritization guidelines to include the category of “allegations of serious harm to a minor.”  
SB 1480 also makes changes to postgraduate license exemptions and to 
postgraduate training programs, all of which become operative on January 1, 2020. At the 
July 2018 meeting, the Licensing Committee presented an update on the changes to 
postgraduate training. The 12-month and 27-month limitations on license exemptions for 
medical school graduates enrolled in first-year postgraduate training programs and 
residencies and fellowships are deleted. There are changes to the duration of some 
postgraduate training programs and licensure procedures upon completion of those 
programs. Directors of California-based postgraduate training programs must report to 
MBC and provide documents regarding a postgraduate trainee’s status in the program 
within 30 days of certain events such as resignation or termination or in the event the 
program is extended.  
Section 2428 is amended to increase the length (from two years to three years) of 
approved postgraduate training an applicant must complete if they are applying for a new 
license after a period of five years of non-renewal after they voluntarily cancelled or failed 
to renew their license. The bill further makes adjustments to the exam and application fee 
structure, including requiring applicants to pay nonrefundable application and processing 
fees. The remainder of the bill does not affect MBC.  
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Governor Jerry Brown signed SB 1480 on September 19, 2018 (Chapter 571, 
Statutes of 2018).  
Legislative Bills that Died  
The following bills reported in Volume 23, No. 2 (Spring 2018) died in committee 
or otherwise failed to be enacted during 2018: AB 2741 (Burke), which would have 
prohibited prescribers from prescribing more than a five-day supply of opioid medication 
to a minor except for specified medical uses; AB 1998 (Rodriguez), which would have 
required prescribers of Schedule II and Schedule III opioids to adopt and regularly update 
a safe opioid prescribing policy; AB 182 (Waldron), relating to the Heroin Opioid 
Education Program; AB 1752 (Low), which would have reduced the timeframe in which 
dispensers must report certain information to CURES from seven days to one day; AB 
1002 (Cooley), which would have required MBC to consult with the California Cannabis 
Research Program to promulgate guidelines regarding medical cannabis; AB 1795 
(Gipson), relating to emergency medical services agencies creating transport plans for 
certain triaged patients directly to a behavioral health facility or sobering center rather than 
an acute care facility; AB 2539 (Mathis), relating to definitional changes and the 
requirements of the Steven M. Thompson Physician Corps Loan Repayment Program; AB 
2904 (Carrillo), which would have required health care providers to document patient 
consent to the use of telehealth; AB 2483 (Voepel), which would have required public 
entities, including MBC, to pay trebled antitrust awards against regulatory board members 
for acts or omissions within the scope of a member’s official capacity as a member of the 
regulatory board; AB 2682 (Burke), which would have expanded the authority of certified 
nurse-midwives to allow them to practice and prescribe in a variety of settings without 
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physician supervision; AB 2943 (Low), which would have reclassified the selling of 
services related to changing the sexual orientation of individuals as an unlawful practice 
under the Consumer Legal Remedies Act; AB 1368 (Calderon), relating to provider 
authority to sign patient forms relating to Medi-Cal benefits and services; AB 18 (Garcia), 
which would have removed a requirement that physician orientation for the Mexico Pilot 
Program be six months in length; SB 944 (Hertzberg), relating to the development of 
community paramedicine programs under the California Emergency Medical Services 
Authority; SB 1238 (Roth), relating to patient rights to access medical records; and SB 
1336 (Morrell), relating to the scope of information included on the annual End of Life 
Option Act Report.  
LITIGATION 
♦ Selvidge v. Tang. On May 16, 2018, the Supreme Court of California denied the 
defendant’s petition for review and request for depublication in Selvidge v. Tang, Case No. 
S248211, 2018 Cal. LEXIS 3548 (May 18, 2018). Defendant petitioned the Supreme Court 
of California for review and requested depublication after the decision in Selvidge v. Tang, 
20 Cal. App. 5th 1279 (2018). [23:2 CRLR 70-72]  
RECENT MEETINGS 
At its April 2018 meeting, MBC voted to appoint Dr. Hawkins to serve as the 
Board’s representative on the Health Professions Education Foundation (HPEF). The 
Board also unanimously voted to change the term limits for HPEF appointees to four years, 
or until the MBC member’s term on the Board expires, whichever comes first.  
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At its July 2018 meeting, the Board elected public member Denise Pines to serve 
as MBC president, and licensee member, Dr. Lewis, to serve as Vice President, and 
licensee member Dr. Bholat as Secretary.  
